Business Context and Reporting Period
This Form 8-K Current Report is filed by CorMedix Inc. (CRMD) on June 25, 2026. The filing addresses a change in the Company's independent registered public accounting firm. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Dismissal of Auditor: The Audit Committee dismissed CBIZ CPAs P.C. as the independent registered public accounting firm effective June 25, 2026.
- Appointment of Successor: The Audit Committee appointed Ernst & Young LLP (EY) as the new independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Historical Context: CBIZ CPAs was previously appointed on April 17, 2025, following the dismissal of Marcum LLP due to an acquisition of Marcum's attest business by CBIZ.
Outlook, Risks, and Contingencies
Reportable Event: The filing discloses one "reportable event" during the tenure of CBIZ CPAs (April 17, 2025, through June 25, 2026):
- A material weakness in internal control over financial reporting, previously reported in the Company's 2025 Form 10-K. This weakness relates to the operational effectiveness of controls ensuring adequate and timely review of significant, non-routine transactions.
Disagreements: The Company states there were no disagreements with CBIZ CPAs regarding accounting principles, financial statement disclosures, or auditing scope/procedures.
Consultations: The Company confirms no consultations with EY regarding accounting or auditing matters prior to their appointment.
Investor Verification Checklist
- Verify the status of the remediation plan for the disclosed material weakness in internal controls over financial reporting.
- Review the letter from CBIZ CPAs (Exhibit 16.1) to confirm their agreement with the Company's statements regarding the dismissal.
- Monitor future filings for the transition timeline and initial audit scope defined by the new auditor, EY.
- Confirm that the change in auditors was not precipitated by undisclosed disagreements or financial irregularities beyond the known material weakness.